The Anti-DLL3 (Rovalpituzumab Tesirine) Biosimilar (HDBS0065) is a cutting-edge product designed for research involving Delta-like protein 3 (DLL3), a cell surface target highly expressed in certain types of cancer cells. This biosimilar antibody, developed for potential therapeutic use, is derived from Rovalpituzumab Tesirine and designed to bind specifically to DLL3, inhibiting its function in cancer progression.The Anti-DLL3 (Rovalpituzumab Tesirine) Biosimilar (HDBS0065) has shown promising results in preclinical studies, demonstrating potent anti-tumor activity in DLL3-expressing cancer models. Its ability to selectively target DLL3-positive cells makes it a valuable tool for studying DLL3 biology and developing targeted therapies for DLL3-driven cancers such as small cell lung cancer and neuroendocrine tumors.
Researchers in oncology and drug development can utilize this biosimilar antibody to investigate the role of DLL3 in cancer development and progression, as well as to evaluate the potential of targeting DLL3 for precision medicine approaches. With its high specificity and efficacy, the Anti-DLL3 (Rovalpituzumab Tesirine) Biosimilar (HDBS0065) offers exciting opportunities for advancing cancer research and developing novel therapies for patients with DLL3-positive malignancies.
Product Name:
Rovalpituzumab (Anti-DLL3) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0065
Target:
DLL3
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
SC0001-SCX,SC0002,sc0001-SCX
Description:
Anti-DLL3(Rovalpituzumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
